The Future of Pharma Across All Sectors in the Artificial Intelligence Era
- 1st Edition - November 1, 2025
- Imprint: Academic Press
- Editors: Miltiadis Lytras, Ahmed M. Shaman, Patricia Ordonez de Pablos, Paraskevi Papadopoulou, Sofia Konstantinopoulou, Sarah Abdulrahman Alajlan
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 4 0 5 7 2 - 3
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 4 0 5 7 3 - 0
The Future of Pharma Across All Sectors in the Artificial Intelligence Era offers a thorough examination of the pharmaceutical industry's current landscape, highlighting the myriad… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteThe Future of Pharma Across All Sectors in the Artificial Intelligence Era offers a thorough examination of the pharmaceutical industry's current landscape, highlighting the myriad challenges, opportunities, and trends that are poised to shape its future. Edited by experts this book delves into the transformative technological advancements that are redefining pharmaceutical research, development, and commercialization, including artificial intelligence, machine learning, big data analytics, and blockchain. The book explores the revolutionary potential of precision medicine, which promises to enhance the pharmaceutical value chain from drug discovery to patient care. It addresses the integration of personalized therapies and genomic medicine while also considering the educational implications for academic curricula. Digital transformation is another focal point, as the book examines how digital technologies are reshaping healthcare delivery models and improving patient engagement and clinical outcomes. Regulatory trends and compliance are scrutinized, offering insights into navigating complex landscapes to ensure product quality and safety. Addressing global health challenges, the book emphasizes the pharmaceutical industry's role in tackling infectious diseases and health disparities, promoting health equity through innovative drug development and access initiatives. Future trends and predictions are speculated upon, considering demographic shifts and evolving healthcare needs, while market dynamics and commercial strategies are analyzed to equip pharmaceutical companies with practical recommendations for navigating competitive landscapes.
- Provides an in-depth examination of the current pharmaceutical landscape, identifying key challenges and opportunities while exploring trends that will shape the future of the industry
- Highlights the transformative impact of emerging technologies such as AI, big data, and blockchain on pharmaceutical research, development, and commercialization, illustrated with real-world case studies
- Addresses critical global health challenges and strategies for improving access to innovative medicines, promoting health equity, and ensuring timely healthcare delivery for underserved populations
Researchers, scientists, and academics in the field of information technologies, frontier research (epidemiology, immunology, virology and other relevant scientific disciplines), pharmacology, pharmaceutical science and medicine as well as policymakers. Also Master and PhD students
1. Introduction: Navigating the Complex Landscape of Pharma
2. Trends Shaping the Future of Pharmaceuticals
3. Traditional Pharmaceuticals: Innovations and Challenges Ahead
4. Biotechnology: Revolutionizing Drug Discovery and Development
5. Generic Drugs and Biosimilars: Opportunities for Access and Affordability
6. Over-the-Counter Medications: Meeting Consumer Needs in the Digital Age
7. Advancements in Vaccines and Immunotherapies
8. Medical Devices and Diagnostics: Enhancing Patient Care and Outcomes
9. Contract Research and Manufacturing Services (CRAMS): Driving Efficiency and Collaboration
10. Regulatory Outlook: Adapting to Evolving Standards and Requirements
11. Global Health Challenges and Access to Medicines
12. Emerging Technologies: Artificial Intelligence, Digital Therapeutics, and Beyond
13. Precision Medicine: Personalizing Treatments for Improved Outcomes
14. Market Dynamics and Commercial Strategies
15. Future Outlook: Anticipating Trends and Opportunities
2. Trends Shaping the Future of Pharmaceuticals
3. Traditional Pharmaceuticals: Innovations and Challenges Ahead
4. Biotechnology: Revolutionizing Drug Discovery and Development
5. Generic Drugs and Biosimilars: Opportunities for Access and Affordability
6. Over-the-Counter Medications: Meeting Consumer Needs in the Digital Age
7. Advancements in Vaccines and Immunotherapies
8. Medical Devices and Diagnostics: Enhancing Patient Care and Outcomes
9. Contract Research and Manufacturing Services (CRAMS): Driving Efficiency and Collaboration
10. Regulatory Outlook: Adapting to Evolving Standards and Requirements
11. Global Health Challenges and Access to Medicines
12. Emerging Technologies: Artificial Intelligence, Digital Therapeutics, and Beyond
13. Precision Medicine: Personalizing Treatments for Improved Outcomes
14. Market Dynamics and Commercial Strategies
15. Future Outlook: Anticipating Trends and Opportunities
- Edition: 1
- Published: November 1, 2025
- Imprint: Academic Press
- No. of pages: 220
- Language: English
- Paperback ISBN: 9780443405723
- eBook ISBN: 9780443405730
ML
Miltiadis Lytras
Miltiadis D. Lytras is an expert in advanced computer science and management, editor, lecturer, and research consultant, with extensive experience in academia and the business sector in Europe and Asia. Dr. Lytras is a Research Professor at Deree College - The American College of Greece and a Distinguished Scientist at the King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia. Dr. Lytras is a world-class expert in the fields of cognitive computing, information systems, technology enabled innovation, social networks, computers in human behavior, and knowledge management. In his work, Dr. Lytras seeks to bring together and exploit synergies among scholars and experts committed to enhancing the quality of education for all.
Affiliations and expertise
Research Professor, Deree College, The American College of Greece, GreeceAS
Ahmed M. Shaman
Ahmed is an experienced professional with almost 2 decades of expertise in pharmaceutical, academia, and healthcare industries. He has strong leadership skills, excellent communication abilities, and an entrepreneurial spirit. He specializes in clinical trials and has a proven track record of designing and running international, multicentre clinical trial projects. He is a thought leader in R&D ecosystem transformation and the use of technology to advance health. He also has a strong network of investigators and key opinion leaders, both locally and globally, and is actively involved in various initiatives to unlock the clinical trials ecosystem. Ahmed is passionate about enabling others to conduct more clinical trials with the ultimate aim of improving the health of millions of people around the world.
Affiliations and expertise
King Saud University, Saudi ArabiaPd
Patricia Ordonez de Pablos
Patricia de Pablos is a Professor of Business Administration at the University of Oviedo in Spain. Her field of research focuses on knowledge management, healthcare sector, innovation, information technologies and technological disruption. She published more than 125 papers in academic journals and more than 35 books. She has wide editorial experience in journals, books and book series. She serves as Editor in Chief of International Journal of Asian Business and Information and Journal of Science and Technology Policy Management. She edited several books and bookseries. In 2021 she was named on “Stanford University’s Ranking of the World Scientists: World’s Top 2% Scientists".
Affiliations and expertise
Professor, Faculty of Economics and Business, The University of Oviedo, SpainPP
Paraskevi Papadopoulou
is Professor of Biology in the Biomedical Sciences Program, Department of Science and Mathematics at Deree-The American College of Greece (Deree-ACG). Her research activity covers a wide range of subject areas with a main focus in the fields of structural biology/molecular biophysics and bioinformatics and on structural and self-assembly studies of fibrous proteins. Her current research engagement expands on environmental health issues, big data analytics in bioinformatics, medicine, health and healthcare, the evolution of consciousness plus on Mediterranean biodiversity and green roofs, and innovative teaching and learning methods in STEM disciplines. https://acg150.acg.edu/persons/paraskevi-papadopoulou-phd/
Affiliations and expertise
Almaarefa University Riyadh, Saudi ArabiaSK
Sofia Konstantinopoulou
Dr Sofia Konstantinopoulou, MD, FAAP, is a triple US board-certified pediatric pulmonologist and sleep medicine physician. She completed her training and gained extensive experience at the Children’s Hospital of Philadelphia, where she also held an academic position as Assistant Professor of Pediatrics at the Perelman School of Medicine at the University of Pennsylvania.
Currently, Dr Konstantinopoulou serves as an attending physician specializing in pediatric pulmonology and sleep medicine at Sheikh Khalifa Medical City (SEHA), the premier referral center for pediatrics in the country. In this role, she manages some of the most challenging cases in pediatric respiratory and sleep medicine, collaborating closely with multidisciplinary teams to deliver compassionate, family-centered care. She also holds the position of clinical lead for the Aerodigestive Program at her institution.
With a primary focus on patients with sleep-disordered breathing requiring home mechanical ventilation, Dr Konstantinopoulou is dedicated to providing high-quality care and improving outcomes for these individuals. She plays a pivotal role in medical education as core faculty for her institution's ACGME-accredited pediatric residency program and the World Sleep Academy (WSA).
Additionally, Dr Konstantinopoulou is actively involved in professional organizations such as CHEST, the American Academy of Sleep Medicine (AASM), and the American Thoracic Society (ATS), where she contributes her expertise as a member of the International Health Committee.
Passionate about collaboration and advancing clinical research, health advocacy, and medical education, Dr Konstantinopoulou welcomes opportunities to work with partners worldwide on impactful projects in her field.
Affiliations and expertise
Sheikh Kalifa Medicl Center, United Arab EmiratesSA
Sarah Abdulrahman Alajlan
Dr. Alajlan is a Dialysis clinical pharmacist and researcher. She has bachelor degree in Doctor of Pharmacy (PharmD) she is member of multiple international and national pharmacy associations. Dr. Alajlan received national and international awards in research project and has multiple publications in the field of social and behaviors, pharmacy, and education.
Affiliations and expertise
Almaarefa University Riyadh, Saudi Arabia